← All diseases Infectious diseases

Chronic hepatitis B

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (82)Meta-analysis (26)Treatment guideline (6)Randomized trial (32)Systematic review (10)Phase 3 study (8)Clinical trial (630)Review Article (168)Early study (phase 1 or 2) (25)Description of individual patients (95)Laboratory or animal research (16)Commentary or Editorial (50)Retracted publication (2) Studies currently recruiting participants only (31)

Filter

Publications and studies (2000)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Clinical significance and occurrence mechanism of hepatitis B virus DNA integration]. (2026/07/20) ♡
• [APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update]. (2026/07/20) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The efficacy of traditional Chinese medicine on immune function in patients with hepatitis B-related liver fibrosis or cirrhosis: a systematic review and meta-analysis. (2026/07/20) ♡
• Concurrent MASLD and Long-term Outcomes in HBV-infected Individuals: A Population-based Cohort Study. (2026/07/20) ♡
• Medication adherence in Chinese adults with chronic hepatitis B based on theory of planned behavior. (2026/07/19) ♡
• AURKA regulates HBV-induced hepatic stellate cell inflammation and liver fibrosis by modulating K48-linked ubiquitination and proteasomal degradation of TLR3. (2026/07/17) ♡
• Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong. (2026/07/17) ♡
• Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral Protein Degradation. (2026/07/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Combined percutaneous auricular vagus nerve stimulation and ultrasound-guided phrenic nerve block for persistent hiccups: A case report. (2026/07/17) ♡
• Trends in the etiology of acute insult and underlying chronic liver disease in patients with acute-on-chronic liver failure: A retrospective study in Southwest China (2020-2023). (2026/07/17) ♡
• Texture Analysis of Non-contrast Magnetic Resonance Imaging for Liver Fibrosis Staging in Patients with Chronic Hepatitis B. (2026/07/17) ♡
• Predictors of Incident High-Risk Varices in Patients with Hepatitis B-related Cirrhosis Receiving Nucleos(t)ide Analogue Therapy. (2026/07/16) ♡
• B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase. (2026/07/16) ♡
• NGS-diagnosed HBV encephalitis with isolated left parietal lobe involvement: a case report. (2026/07/16) ♡
• Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B. (2026/07/15) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature? (2026/07/15) ♡
• Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B. (2026/07/15) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Safety and efficacy of libevitug in patients with chronic hepatitis B and D virus coinfection: A single-center, open-label, phase IIa trial in China. (2026/07/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Serum M2BPGi as a predictor of hepatocellular carcinoma development in chronic hepatitis B and C: a systematic review and meta-analysis. (2026/07/15) ♡
• Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching. (2026/07/14) ♡
• Long-Term Incidence of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance. (2026/07/13) ♡
• Hypovitaminosis D-Induced Secondary Hyperparathyroidism With Concomitant Femoral Fracture in a Chronic Hepatitis B Patient: A Case Report. (2026/07/13) ♡
• Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. (2026/07/11) ♡
• Correlation of Insulin and/or Insulin Secretagogues with the Risk of Hepatocellular Carcinoma and All-Cause Mortality Among Patients with Chronic Hepatitis B and Type 2 Diabetes Mellitus: A Retrospective Cohort Study. (2026/07/09) ♡
• Discriminative Role of Interleukin-6, Neuropilin-1, and Amphiregulin for Cirrhosis in Patients with Chronic Hepatitis B Infection. (2026/07/09) ♡
• Integrating Mendelian randomization, machine learning and retrospective clinical data: an exploratory analysis of the cross-disease association between CHB and PD, with a focus on eosinophil alterations. (2026/07/09) ♡
• Clinical burden, disease progression, and management strategies in chronic hepatitis B: implications for public health practice. (2026/07/09) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PD-1/PD-L1 blockade as part of combination strategies toward functional cure of chronic hepatitis B. (2026/07/09) ♡
• Peg-IFNα reduces clinical severity but cannot prevent COVID-19 infection in chronic hepatitis B patients: a cohort study in China. (2026/07/08) ♡
• Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure. (2026/07/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multidrug-resistant Shewanella putrefaciens isolated from ascitic fluid in a patient with decompensated cirrhosis: A case report. (2026/07/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From exhaustion to functional cure: frontiers in reversing HBV-specific T-cell immunity. (2026/07/06) ♡
• Effect of pegylated interferon α-2b on low-density lipoprotein in patients with chronic hepatitis B. (2026/07/03) ♡
• Modular delivery of co-stimulatory signals through a PD-1-based immunoswitch receptor improves the functionality of Hepatitis B Virus-specific engineered T cells. (2026/07/03) ♡
• Comparative evaluation of noncontrast computed tomography (CT) histogram analysis, FibroScan, and serum markers for liver fibrosis assessment in chronic hepatitis B patients. (2026/07/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Liver Macrophages in the Pathogenesis of Viral Hepatitis. (2026/07/03) ♡
• Interactive Roles of Metabolic Dysfunction-Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection. (2026/07/03) ♡
• Chronic Rhinosinusitis and Premorbid Gastrointestinal Tract Diseases: A Population-Based Case-Control Study. (2026/07/01) ♡
• The role of liver stiffness measurement in predicting Long-term liver function after partial hepatectomy. (2026/07/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Comment on the expert consensus on treatment approaches for achieving functional cure in chronic hepatitis B: Letter to the editor on "Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0". (2026/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Functional cure of infants with HBeAg-positive chronic hepatitis B receiving antiviral treatment: Case series. (2026/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. First-in-human study on the pharmacokinetics, safety, and tolerability of single escalating doses and multiple doses of XT1061, a novel core protein allosteric modulator, in healthy Chinese subjects. (2026/06/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Apremilast for acquired reactive perforating collagenosis with metabolic and infectious comorbidities: a case report. (2026/06/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genome-Wide Association Studies in Hepatocellular Carcinoma: Aetiology-Specific Susceptibility, Functional Interpretation, and Clinical Translation. (2026/06/30) ♡
• Aloe emodin isolated from Cassiae semen upregulates IFITM1 to suppress hepatitis B virus replication via the interferon signaling pathway. (2026/06/30) ♡
• Efficacy and safety of combining TACE with atezolizumab/bevacizumab versus TACE alone: a retrospective propensity score-matched cohort study in HBV-related hepatocellular carcinoma. (2026/06/29) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The clinical significance and optimization strategies of HBeAg seroclearance in chronic hepatitis B treatment. (2026/06/29) ♡
• Chronic Hepatitis B in the Asia-Pacific Region: Results of the 2023 Global Burden of Disease Study. (2026/06/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Short-chain Fatty Acids and Bile Acids Signaling in Chronic Hepatitis B. (2026/06/28) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor: Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study. (2026/06/28) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.